اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 24, Issue 2 (ویژه نامه پزشکی فرد محور- فروردین و اردیبهشت 1401) ::
Koomesh 1401, 24(2): 197-209 Back to browse issues page
Clinical application of gut microbiota metabolites: A novel opportunity in personalized medicine
Zahra Hoseini Tavassol , Hanieh-Sadat Ejtahed , Ahmad-Reza Soroush , Arefeh Shahriari , Seyed-Davar Siadat , Shirin Hasani-Ranjbar , Shekoufeh Nikfar , Bagher Larijani
Abstract:   (1488 Views)
Nowadays, metabolomics studies are performed with different approaches to identify biomarkers, clarify the underlying mechanisms of diseases and achieve novel treatment strategies. In this context, gut microbiota-derived metabolites are known as one of the most important mediators of gut microbiota effects on human health and various diseases. Due to the inefficiency of conventional therapies in some cases, personalized medicine is of great clinical importance. Recent studies have shown that alterations in gut microbiota metabolites like short-chain fatty acids (SCFAs), amino acids, bile acid metabolites, and choline metabolites can link gut microbiota to numerous chronic non-communicable diseases including obesity, diabetes, inflammatory bowel diseases, psychological disorders, cardiovascular diseases and cancers. Understanding the composition of gut microbiota and the relationship between its derived-metabolites and the occurrence of various diseases is necessary to achieve new clinical applications. Furthermore, potential therapeutic agents such as prebiotic supplements and next-generation probiotics, dietary interventions, antibiotics, and fecal microbiota transplantation (FMT) could be among the leading strategies for personalized medicine in prognosis, diagnosis and treatment of various diseases, via modulating the diversity and composition of gut microbiota and its metabolites
Keywords: Gastrointestinal Microbiome, Metabolomics, Metabolome, Precision Medicine
Full-Text [PDF 1354 kb]   (497 Downloads)    
Type of Study: Review | Subject: review
Received: 2021/04/26 | Accepted: 2021/07/7 | Published: 2022/03/19
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hoseini Tavassol Z, Ejtahed H, Soroush A, Shahriari A, Siadat S, Hasani-Ranjbar S, et al . Clinical application of gut microbiota metabolites: A novel opportunity in personalized medicine. Koomesh 1401; 24 (2) :197-209
URL: http://koomeshjournal.semums.ac.ir/article-1-7011-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 2 (ویژه نامه پزشکی فرد محور- فروردین و اردیبهشت 1401) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645